New presentations include final 64-week results from the Phase 3 QUASAR trial in patients with retinal vein occlusion, as well as full primary results from the Phase 3b ELARA trial in patients treated ...
In addition to demonstrating that the vision gains and anatomic achievements or improvements with EYLEA HD over two years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results